CPH.AX - Creso Pharma Limited
| Previous close | 0.2650 |
| Open | 0.2650 |
| Bid | 0.2600 x 0 |
| Ask | 0.2650 x 0 |
| Day's range | 0.2500 - 0.2650 |
| 52-week range | 0.2500 - 0.5900 |
| Volume | 533,997 |
| Avg. volume | 174,761 |
| Market cap | 40.159M |
| Beta (3Y monthly) | 3.22 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.1110 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Motley Fool
Why this ASX cannabis share price is in limbo today
Trading in shares of Althea Group Holdings Ltd (ASX: AGH) has been halted amid reports that a major shareholder and supplier is heading for the door.The post Why this ASX cannabis share price is in limbo today appeared first on Motley Fool Australia.
- Motley Fool
The cannabis collapse: ASX marijuana shares going cheap
Investors have pulled back from marijuana shares as the sector begins to mature and the adverse publicity surrounding vaping takes its toll. But has the sell down been overdone?The post The cannabis collapse: ASX marijuana shares going cheap appeared first on Motley Fool Australia.
- Motley Fool
Why these ASX cannabis shares are being smoked
The AusCann Group Holdings Ltd (ASX:AC8) share price is one of three in the cannabis industry hitting a 52-week low...The post Why these ASX cannabis shares are being smoked appeared first on Motley Fool Australia.
- Motley Fool
Why BWX, Creso Pharma, Mayne Pharma, & St Barbara shares dropped lower
The Mayne Pharma Group Ltd (ASX:MYX) share price and the St Barbara Ltd (ASX:SBM) share price are two of four ending the week deep in the red...
- Motley Fool
Why these ASX cannabis shares are on the move today
BOD Australia Ltd (ASX:BDA), Creso Pharma Limited (ASX:CPH), and MGC Pharmaceuticals Ltd (ASX:MXC) shares are on watch today after making announcements...
- Motley Fool
This ASX cannabis share could soon be taken over
The Creso Pharma Ltd (ASX:CPH) share price remains suspended following the release of a takeover update...
- ACN Newswire
Creso Pharma Gears Up for Adult-Use Market with New Supply Agreement -- CFN Media
SEATTLE, WA, Jan 24, 2019 - (ACN Newswire) - via NEWMEDIAWIRE -- CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing Creso Pharma Ltd. (ASX:CPH.AX - News) and its unique position with near-term production, existing supply agreements, and an established European cannabidiol (CBD) line of products. Canada's cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte analysts, driven by the legalization of adult-use cannabis in October of last year. While many licensed producers have been scaling up their production, the market continues to experience a shortfall in supply that has created an opportunity for investors in companies with near-term production coming online.
- ACN Newswire
Creso Pharma Targets Multi-Billion Dollar Pet Industry -- CFN Media
SEATTLE, WA, Jan 16, 2019 - (ACN Newswire) - via NEWMEDIAWIRE -- CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing Creso Pharma Inc. (ASX:CPH.AX - News) and why it's well positioned to capitalize on the rapid growth in the pet CBD market. Global consumers spend billions of dollars on their pets each year, according to GfK, with two-thirds of sales taking place in the United States and Europe. In the U.S. alone, the American Pet Products Association reckons that consumers spent more than $72 billion on their pets in 2018, including about $30 billion on food, $15 billion on supplies and over-the-counter medicine, and $20 billion on veterinary care.
- GlobeNewswire
Creso Looks to Capitalize on Domestic & Foreign Legislation -- CFN Media
SEATTLE, Jan. 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing Creso Pharma Inc. (ASX:CPH), new legislation, and how it aims to become one of the world’s most trusted suppliers of cannabis and hemp-derived products by combining pharmaceutical rigor, good manufacturing practices (GMP) standards, and proprietary delivery technologies. The cannabis industry is driven primarily by legislation—whether it’s the legalization of adult-use cannabis across a growing number of countries or more nuanced legal moves. Over the past few months, two pieces of legislation could have a significant impact on the global cannabis industry: The passage of the 2018 Farm Bill in the United States and the legalization of medical cannabis exports in Israel.
- ACN Newswire
Creso Pharma Brings Together Cannabis Experts Across Several Verticals -- CFN Media
SEATTLE, WA, Dec 19, 2018 - (ACN Newswire) - via NEWMEDIAWIRE -- CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing Creso Pharma Ltd. (ASX:CPH.AX - News), a small-cap company founded in 2016 that has amassed one of the most experienced management teams in the cannabis industry. Small-cap stocks tend to be earlier stage companies without an established earnings track record, which means that investors must consider the management team above all else. In this article, we will take a closer look at the company's management team and advisory board, as well as how their expertise have helped drive progress.
- GlobeNewswire
Creso Pharma Brings Together Cannabis Experts Across Several Verticals-- CFN Media
CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing Creso Pharma Ltd. (ASX:CPH), a small-cap company founded in 2016 that has amassed one of the most experienced management teams in the cannabis industry. Small-cap stocks tend to be earlier stage companies without an established earnings track record, which means that investors must consider the management team above all else. In this article, we will take a closer look at the company’s management team and advisory board, as well as how their expertise have helped drive progress.
- ACN Newswire
Creso Pharma: A Truly Global Cannabis Company -- CFN Media
SEATTLE, WA, Dec 6, 2018 - (ACN Newswire) - via NEWMEDIAWIRE -- CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing Creso Pharma's (ASX:CPH.AX - News) innovative approach, diverse product portfolio, and why investors may want to take a closer look as it gears up to go public on the Venture exchange in Canada. The listing would make Creso the first public cannabis company listed in both Australia and Canada. The North American cannabis industry is littered with companies touting global ambitions.
- GlobeNewswire
Creso Pharma: A Truly Global Cannabis Company-- CFN Media
SEATTLE, Dec. 05, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing Creso Pharma’s (ASX:CPH) innovative approach, diverse product portfolio, and why investors may want to take a closer look as it gears up to go public on the Venture exchange in Canada. The listing would make Creso the first public cannabis company listed in both Australia and Canada. The North American cannabis industry is littered with companies touting global ambitions.
